[go: up one dir, main page]

DE602006013009D1 - Pharmazeutische zusammensetzung von mahanin zur behandlung von prostatakrebs - Google Patents

Pharmazeutische zusammensetzung von mahanin zur behandlung von prostatakrebs

Info

Publication number
DE602006013009D1
DE602006013009D1 DE602006013009T DE602006013009T DE602006013009D1 DE 602006013009 D1 DE602006013009 D1 DE 602006013009D1 DE 602006013009 T DE602006013009 T DE 602006013009T DE 602006013009 T DE602006013009 T DE 602006013009T DE 602006013009 D1 DE602006013009 D1 DE 602006013009D1
Authority
DE
Germany
Prior art keywords
mahanine
treatment
pharmaceutical composition
prostate cancer
prostate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006013009T
Other languages
English (en)
Inventor
Swati Sinha
Bikas Chandra Pal
Samir Bhattacharya
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Council of Scientific and Industrial Research CSIR
Original Assignee
Council of Scientific and Industrial Research CSIR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Council of Scientific and Industrial Research CSIR filed Critical Council of Scientific and Industrial Research CSIR
Publication of DE602006013009D1 publication Critical patent/DE602006013009D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE602006013009T 2005-09-01 2006-08-25 Pharmazeutische zusammensetzung von mahanin zur behandlung von prostatakrebs Active DE602006013009D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2335DE2005 2005-09-01
PCT/IB2006/002317 WO2007026203A1 (en) 2005-09-01 2006-08-25 A pharmaceutical composition comprising mahanine useful for the treatment of prostate cancer

Publications (1)

Publication Number Publication Date
DE602006013009D1 true DE602006013009D1 (de) 2010-04-29

Family

ID=37507756

Family Applications (2)

Application Number Title Priority Date Filing Date
DE112006002340T Withdrawn DE112006002340T5 (de) 2005-09-01 2006-08-22 Arzneimittel, verwendbar zur Behandlung von Prostatakrebs
DE602006013009T Active DE602006013009D1 (de) 2005-09-01 2006-08-25 Pharmazeutische zusammensetzung von mahanin zur behandlung von prostatakrebs

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE112006002340T Withdrawn DE112006002340T5 (de) 2005-09-01 2006-08-22 Arzneimittel, verwendbar zur Behandlung von Prostatakrebs

Country Status (6)

Country Link
US (3) US20070072931A1 (de)
EP (1) EP1933945B1 (de)
CN (2) CN101252945A (de)
DE (2) DE112006002340T5 (de)
GB (1) GB2443588B (de)
WO (2) WO2007026201A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009066303A2 (en) 2007-11-22 2009-05-28 Ganga Raju Gokaraju New synergistic phytochemical composition for the treatment of obesity
WO2010019271A1 (en) 2008-08-15 2010-02-18 Georgetown University Fluorescent regulators of rassf1a expression and human cancer cell proliferation
US8637679B2 (en) 2011-03-11 2014-01-28 Council Of Scientific And Industrial Research Process for the isolation of organic compounds useful for the treatment of cancer
CN102634480B (zh) * 2012-03-27 2013-12-18 中国农业大学 一种分离培养肝脏原代细胞的方法
CN102935130B (zh) * 2012-12-08 2014-03-19 新乡医学院 一种提高缺氧耐受力的中药组合物及其制备方法和应用
US11053255B2 (en) 2015-06-22 2021-07-06 Georgetown University Synthesis of mahanine and related compounds
CN118108727B (zh) * 2024-04-29 2024-06-28 昆明医科大学 一种咔唑生物碱类化合物及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3346083B2 (ja) * 1995-02-24 2002-11-18 ライオン株式会社 抗菌剤及び口腔用組成物
JP3497655B2 (ja) * 1996-03-07 2004-02-16 稲畑香料株式会社 口臭予防用及び口臭除去用の食品並びに口臭予防及び口臭除去剤
US6746694B1 (en) * 2000-10-02 2004-06-08 Council Of Scientific And Industrial Research Herbal composition for treating asthma
US20030096020A1 (en) * 2001-06-04 2003-05-22 Brindavanam Narasimha Baba Novel herbal composition for the management of bronchial asthma and a process of manufacturing the same
US6818231B2 (en) * 2001-12-12 2004-11-16 Brian Alexis Treatment of vulvovaginitis with spirostanol enriched extract from Tribulus terrestris
BG106435A (bg) * 2002-02-25 2003-09-30 АЛЕКСИЕВ Благой Фармакологична композиция
BG106434A (bg) * 2002-02-25 2003-09-30 АЛЕКСИЕВ Благой Фармакологична субстанция

Also Published As

Publication number Publication date
CN101267859A (zh) 2008-09-17
US20100297760A1 (en) 2010-11-25
DE112006002340T5 (de) 2008-07-17
EP1933945A1 (de) 2008-06-25
US20070104811A1 (en) 2007-05-10
WO2007026203A1 (en) 2007-03-08
WO2007026201A1 (en) 2007-03-08
CN101267859B (zh) 2013-01-02
GB0803521D0 (en) 2008-04-02
CN101252945A (zh) 2008-08-27
EP1933945B1 (de) 2010-03-17
US20070072931A1 (en) 2007-03-29
GB2443588A (en) 2008-05-07
GB2443588B (en) 2010-04-21

Similar Documents

Publication Publication Date Title
ATE527241T1 (de) Pyridiazinonderivate zur behandlung von tumoren
EP1765391A4 (de) Bakterielle zusammensetzungen zur behandlung von krebs
IS8398A (is) Lyfjasamsetningar til að meðhöndla æxli
HUE054495T2 (hu) Rák kezelésére szolgáló készítmény
ZA200707638B (en) Pharmaceutical composition comprising an omega-carboxyaryl substituted diphenyl urea for the treatment of cancer
DE602006019560D1 (de) 2-cyanobenzolsulfonamidverbindungen zur behandlung von samen
EP1851237A4 (de) Pharmazeutische zusammensetzungen zur behandlung oder prävention von knochenerkrankungen
ATE512663T1 (de) Kombination zur behandlung von erkrankungen mit zellproliferation
CL2007000161A1 (es) Compuestos derivados de 2,4-dioxoimidazolidina sustituida, inhibidores de proteinas cinasas; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer.
IL188430A0 (en) Treatment of tumors
ATE538652T1 (de) Synergistische pharmazeutische kombination für die behandlung von krebs
ATE534633T1 (de) Indazolderivate zur behandlung von hsp90- induzierten krankheiten
IS8125A (is) Kínasólínafleiður til að meðhöndla krabbamein
ATE443704T1 (de) Pyridopyrimidinone zur behandlung von krebserkrankungen
DE602005021970D1 (de) Verwendung von peptidverbindungen zur behandlung von schmerzen durch knochenkrebs, chemotherapie- und nucleosid-bedingten schmerzen
DE602004021435D1 (de) Injizierbare zusammensetzung zur behandlung von krebs
EP1796729A4 (de) Liposome mit verbesserter arzneirückhaltung zur behandlung von krebs
EP1965827A4 (de) Behandlung von entmyelinisierenden erkrankungen
DE602007009877D1 (de) Isosorbid-mononitrat-derivate zur behandlung von darmerkrankungen
ATE482709T1 (de) Neue arzneimittelkombinationen zur behandlung von atemwegserkrankungen
ATE504297T1 (de) Visnadin zur behandlung von kopfhautjucken
DK1803456T5 (da) Farmaceutiske sammensætninger omfattende L-733060 til anvendelse ved behandling af cancertumorer
DE602006017367D1 (de) Amino-oxo-indolyliden-verbindungen zur verwendung in der behandlung von juckender kopfhaut
DE602006013009D1 (de) Pharmazeutische zusammensetzung von mahanin zur behandlung von prostatakrebs
DE602006003094D1 (de) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin-derivate zur behandlung von unfruchtbarkeit

Legal Events

Date Code Title Description
8364 No opposition during term of opposition